fbxo11 targets bcl6 degradation inactivated diffuse large b-cell lymphomas 
bcl6 product proto-oncogene implicated pathogenesis human b-cell lymphomas binding specific dna sequences bcl6 controls transcription variety genes involved b-cell development differentiation activation bcl6 overexpressed majority patients aggressive diffuse large b-cell lymphoma dlbcl common lymphoma adulthood transgenic mice constitutively expressing bcl6 b cells develop dlbcls similar human disease many dlbcl patients bcl6 overexpression achieved translocation similar % hypermutation promoter similar % however many dlbcls overexpress bcl6 unknown mechanism show bcl6 targeted ubiquitylation proteasomal degradation skp1-cul1-f-box protein scf ubiquitin ligase complex contains orphan f-box protein fbxo11 refs gene encoding fbxo11 found deleted mutated multiple dlbcl cell lines inactivation fbxo11 correlated increased levels stability bcl6 similarly fbxo11 either deleted mutated primary dlbcls notably tumour-derived fbxo11 mutants displayed impaired ability induce bcl6 degradation reconstitution fbxo11 expression fbxo11-deleted dlbcl cells promoted bcl6 ubiquitylation degradation inhibited cell proliferation induced cell death fbxo11-deleted dlbcl cells generated tumours immunodeficient mice tumorigenicity suppressed fbxo11 reconstitution reveal molecular mechanism controlling bcl6 stability propose mutations deletions fbxo11 contribute lymphomagenesis bcl6 stabilization deletions/mutations found dlbcls largely monoallelic indicating fbxo11 haplo-insufficient tumour suppressor gene 
